BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29563811)

  • 1. CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis.
    Zhang ZX; Zhang WN; Sun YY; Li YH; Xu ZM; Fu WN
    Onco Targets Ther; 2018; 11():1323-1331. PubMed ID: 29563811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
    Qu SY; Sun YY; Li YH; Xu ZM; Fu WN
    Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway.
    Yue PJ; Sun YY; Li YH; Xu ZM; Fu WN
    Cell Signal; 2020 Oct; 74():109709. PubMed ID: 32659265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
    Wang PP; Ding SY; Sun YY; Li YH; Fu WN
    Front Oncol; 2020; 10():564733. PubMed ID: 33680912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression.
    Liu Z; Liu X; Li Y; Ren P; Zhang C; Wang L; Du X; Xing B
    Cancer Manag Res; 2019; 11():5317-5332. PubMed ID: 31239781
    [No Abstract]   [Full Text] [Related]  

  • 7. MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.
    Wang HT; Tong X; Zhang ZX; Sun YY; Yan W; Xu ZM; Fu WN
    FEBS J; 2019 Oct; 286(19):3892-3908. PubMed ID: 31152622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
    Xu XP; Peng XQ; Yin XM; Liu Y; Shi ZY
    Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
    Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
    Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
    Tao W; Tian G; Xu S; Li J; Zhang Z; Li J
    Cancer Cell Int; 2021 Aug; 21(1):413. PubMed ID: 34362389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYCT-1 Gene Expression in Patients with Gastric Cancer: an Ex Vivo Study.
    Dong X; Xue S; Chen C; Jiang Z; Wu X; Wang W
    Appl Biochem Biotechnol; 2023 Dec; ():. PubMed ID: 38112991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells
    Fu S; Fu Y; Chen F; Hu Y; Quan B; Zhang J
    Front Pharmacol; 2018; 9():1045. PubMed ID: 30283340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYCT1 in cancer development: Gene structure, regulation, and biological implications for diagnosis and treatment.
    Xu J; Sun Y; Fu W; Fu S
    Biomed Pharmacother; 2023 Sep; 165():115208. PubMed ID: 37499454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.
    Pu J; Wang J; Xu Z; Lu Y; Wu X; Wu Y; Shao Z; Tang Q; Wei H
    Hum Gene Ther Clin Dev; 2019 Jun; 30(2):67-73. PubMed ID: 30982352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyltransferase 10 promotes cutaneous wound repair via the NF-κB-IL-6 axis.
    Wang B; Zhang J; Li G; Xu C; Yang L; Zhang J; Wu Y; Liu Y; Liu Z; Wang M; Li J; Tang X; Liu B
    Cell Death Discov; 2023 Aug; 9(1):324. PubMed ID: 37644005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma.
    Tan Y; Zheng J; Liu X; Lu M; Zhang C; Xing B; Du X
    Biochem Biophys Res Commun; 2018 May; 499(4):1032-1038. PubMed ID: 29634924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane domain is crucial to the subcellular localization and function of Myc target 1.
    Wu S; Gui J; Yin X; Pan Q; Liu X; Chu L
    J Cell Mol Med; 2016 Mar; 20(3):471-81. PubMed ID: 26710964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma.
    Pan Z; Bao Y; Hu M; Zhu Y; Tan C; Fan L; Yu H; Wang A; Cui J; Sun G
    Cell Death Discov; 2023 Feb; 9(1):56. PubMed ID: 36765042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition.
    Ma R; Chen J; Jiang S; Lin S; Zhang X; Liang X
    Am J Transl Res; 2016; 8(10):4215-4223. PubMed ID: 27830005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3β-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion.
    Zhang H; Hou W; Wang HL; Liu HJ; Jia XY; Zheng XZ; Zou YX; Li X; Hou L; McNutt MA; Zhang B
    Clin Cancer Res; 2014 Sep; 20(17):4717-29. PubMed ID: 24982245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.